Brain glutathione levels–a novel biomarker for mild cognitive impairment and Alzheimer's disease

PK Mandal, S Saharan, M Tripathi, G Murari - Biological psychiatry, 2015 - Elsevier
Background Extant data from in vivo animal models and postmortem studies indicate that
Alzheimer's disease (AD) pathology is associated with reduction of the brain antioxidant …

Brain glutathione levels—A novel biomarker for mild cognitive impairment and Alzheimer's disease.

PK Mandal, S Saharan, M Tripathi, G Murari - Biological Psychiatry, 2015 - psycnet.apa.org
Abstract [Correction Notice: An Erratum for this article was reported in Vol 79 (1) of Biological
Psychiatry (see record 2015-56224-011). In the original article, there is a typographical error …

Brain Glutathione Levels–A Novel Biomarker for Mild Cognitive Impairment and Alzheimer's Disease

PK Mandal, S Saharan… - Biological …, 2015 - biologicalpsychiatryjournal.com
Background Extant data from in vivo animal models and postmortem studies indicate that
Alzheimer's disease (AD) pathology is associated with reduction of the brain antioxidant …

[PDF][PDF] Brain Glutathione Levels–A Novel Biomarker for Mild Cognitive Impairment and Alzheimer's Disease

PK Mandal, S Saharan, M Tripathi, G Murari - researchgate.net
ABSTRACT BACKGROUND: Extant data from in vivo animal models and postmortem
studies indicate that AlzheimerLs disease (AD) pathology is associated with reduction of the …

[引用][C] Brain Glutathione Levels–A Novel Biomarker for Mild Cognitive Impairment and Alzheimer's Disease

PK Mandal, S Saharan, M Tripathi, G Murari - Biological Psychiatry, 2015 - cir.nii.ac.jp
Brain Glutathione Levels – A Novel Biomarker for Mild Cognitive Impairment and Alzheimer’s
Disease | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 …

Brain glutathione levels--a novel biomarker for mild cognitive impairment and Alzheimer's disease

PK Mandal, S Saharan, M Tripathi… - Biological …, 2015 - pubmed.ncbi.nlm.nih.gov
Background Extant data from in vivo animal models and postmortem studies indicate that
Alzheimer's disease (AD) pathology is associated with reduction of the brain antioxidant …

Brain glutathione levels--a novel biomarker for mild cognitive impairment and Alzheimer's disease.

PK Mandal, S Saharan, M Tripathi, G Murari - Biological Psychiatry, 2015 - europepmc.org
Background Extant data from in vivo animal models and postmortem studies indicate that
Alzheimer's disease (AD) pathology is associated with reduction of the brain antioxidant …

Brain Glutathione Levels–A Novel Biomarker for Mild Cognitive Impairment and Alzheimer's Disease

PK Mandal, S Saharan, M Tripathi, G Murari - Biological Psychiatry, 2015 - infona.pl
Extant data from in vivo animal models and postmortem studies indicate that Alzheimer's
disease (AD) pathology is associated with reduction of the brain antioxidant glutathione …

Brain glutathione levels--a novel biomarker for mild cognitive impairment and Alzheimer's disease

PK Mandal, S Saharan, M Tripathi, G Murari - Biol Psychiatry, 2015 - nbrc.sciencecentral.in
BACKGROUND: Extant data from in vivo animal models and postmortem studies indicate
that Alzheimer's disease (AD) pathology is associated with reduction of the brain antioxidant …

Brain glutathione levels--a novel biomarker for mild cognitive impairment and Alzheimer's disease

PK Mandal, S Saharan, M Tripathi, G Murari - Biol Psychiatry, 2015 - nbrc.sciencecentral.in
BACKGROUND: Extant data from in vivo animal models and postmortem studies indicate
that Alzheimer's disease (AD) pathology is associated with reduction of the brain antioxidant …